Log in or Sign up for Free to view tailored content for your specialty!
Mood Disorders News
Long-term data shows efficacy, safety of valbenazine for tardive dyskinesia
SAN DIEGO — Data showing long-term efficacy and pharmacokinetic profile of Ingrezza capsules, recently approved by the FDA for treatment of tardive dyskinesia, was presented at the American Psychiatric Association Annual Meeting.
Understand the early characteristics of tardive dyskinesia, instead of ignoring them
SAN DIEGO — Psychiatrists for too long have had a “desire to not be aware of the problem” of tardive dyskinesia, according a psychiatrist presenting at an industry press conference.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Genetic predictors of tardive dyskinesia
SAN DIEGO — In this video, James L. Kennedy, MD, of the Centre for Addiction and Mental Health, Toronto, discusses the use of genetic factors to predict risk for tardive dyskinesia, a common side effect of psychiatric medications.
FDA approves generic Seroquel XR tablets
Pharmadax Inc. recently announced that the FDA approved a generic version of Seroquel XR tablets for schizophrenia and specific symptoms in bipolar disorder and depression.
Low-income children with chronic conditions at risk for significant costs without CHIP renewal
Low-income children with chronic conditions and their families could experience drastic cost increases for health care — as much as $233 to $2,472 in annual expenditures, depending on income levels and individual needs — if the Children’s Health Insurance Program is not renewed and the families are switched to Marketplace health insurance plans.
Spotlight on depression: Antidepressants, memory, expectant fathers and more
Depression Awareness Week, which runs from May 7 to 13, provides the opportunity to revisit some of the most popular depression research thus far in 2017.
Postpartum depression study app expands to Android, Canada
The University of North Carolina recently launched a version of PPD ACTTM, a mobile app-based study of postpartum depression, for Android operating systems.
FDA grants 510k clearance to MagVita TMS
The FDA recently granted 510k clearance to market MagVita TMS therapy, a repetitive transcranial magnetic stimulation system, for treatment of depression.
Gun access higher among youth with violent, mental health history
Youth who screened positive for ADHD, conduct problems, violence and aggression were more likely to report increased access to firearms, according to data presented at the Pediatric Academic Societies Meeting.
Teen angst may indicate depression risk to PCPs
Common expressions of teen angst may indicate the need for further evaluation for depression among adolescents, according to findings presented at the Pediatric Academic Societies Meeting.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read